Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-115

questions that the asx need to ask;

when did they decide to change the trial, and who exactly knew?

when did they know about the tbi ema odd? My concern is that it was a liquidity play for mates

when was the application for the odd lodged and did they know iih was slow/wrong

did the seller from the last month or three have access to the company directors?

questions from me- how the hell did they not anticipate the design was flawed when designing it? There are a few KOL in the group.

so disappointing that they threw this out there and closed the blinds today.